Do calcium antagonists cause death, gastrointestinal bleeding, and cancer?

American Journal of Cardiology

Volumn 78, Issue 8, 1996, Pages 932-933

  Kaplan, Norman M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; HYPERTENSION; NEOPLASM;

CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; NEOPLASMS;

EID: 0030587849     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kaplan NM. Do calcium antagonists cause myocardial infarction [editorial]. Am J Cardioal 1996;77:81-82.
2. Aursnes I, Litleskare I, Frøyland H, Abdelnoor M. Association between various drugs used for hypertension and risk of acute myocardial infarction. Blood Pressure 1995;4:157-163.
3. Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with entihypertensive drug treatment in persons with uncomplicated essential hypertension Pharmacotherapy 1996;16:321-326.
4. Braun S, Boyko V, Behar S, Reicher-Reiss H, Shotan A, Schlesinger Z, Rosenfeld T, Palant A, Friedensohn A, Laniado S, Goldhourt U. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol 1996;28:7-11.
5. Mayes LC, Horwitz RI, Feinstein AR. A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol 1988;17;680-085,
6. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH. Furberg CD The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
7. Packer M. The PRAISE trial (Prospective Randomized Amlodipine Survival Evaluation); background and main results. Presented at the American College of Cardiology Annual Meeting, March 21, 1995, New Orleans, LA. Cited in Formulary 1995;30:253-258.
8. Gong LS, Hamet P. Shanghai Trial of Nifedipine in the Elderly (STONE) (abstr). Am J Hypertens 1996;9:192A.
9. Pahor M, Ouralnik JM, Corti M-C, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
10. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-1065.
11. Pahor M, Guralnik JM, Salive ME, Corti M-C, Carbonin P. Havlik RJ, Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996;9:695-699.
12. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. β blockers and sudden cardiac death. Ann Intern Med 1995;123:358-367.
13. Hoes AW, Grobbee DE, Lubsen J, Man in't Veld AJ, van der Does E, Hofman A. Diuretics, β-blockers, and the risk for sudden cardiac death in by pertensive patients. Ann Intern Med 1995;123:481-487.
14. Young JB. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials. Cardiovasc Drugs Ther 1995;9:89-102.
15. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
16. Kaplan NM, Gifford RW Jr. Choice of initial therapy for hypertension. JAMA 1996;275:1577-1580.